Urelumab 是一种全人源、非配体结合型的 CD137 激动性 IgG4 单克隆抗体，能够增强 T 细胞和自然杀伤细胞的抗肿瘤活性。

Purity:SDS-PAGE

Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab) is 97.3%, determined by SEC-HPLC.

Bioactivity:ELISA

Immobilized N His HSA TNFSF9/4 1BB at 2 ug/mL can bind Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab), EC50=0.008304 ug/mL.

Bioactivity:FACS

4-1BB-NF-B-Jurkat cells were stained with Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.012 ug/mL.

-25~-15℃保存，有效期1年。